Acute effects of different "exercise snacking'' modalities on glycemic control in patients with type 2 diabetes mellitus (T2DM): study protocol for a randomized controlled trial

被引:0
|
作者
Lazic, Anja [1 ]
Dankovic, Goran [1 ]
Korobeinikov, Georgy [2 ]
Cadenas-Sanchez, Cristina [3 ,4 ]
Trajkovic, Nebojsa [1 ]
机构
[1] Univ Nis, Fac Sport & Phys Educ, Nish 18000, Serbia
[2] Natl Univ Ukraine Phys Educ & Sport Ukraine, Kyiv, Ukraine
[3] Univ Granada, Sport & Hlth Univ Res Inst IMUDS, Fac Sports Sci, Dept Phys Educ & Sports,CIBEROBN,ISCIII, Granada, Spain
[4] Stanford Univ, Dept Cardiol, Vet Affair Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
Diabetes; High intensity interval training; Blood glucose; Accumulated exercise; Continuous glucose monitoring; INTENSITY INTERVAL EXERCISE; PHYSICAL-ACTIVITY; REGULAR EXERCISE; INSULIN SENSITIVITY; HYPERGLYCEMIA; PREVALENCE; STRATEGY;
D O I
10.1186/s12889-025-21669-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundImpaired glycemic control, a sedentary lifestyle and diabetes related consequences are common challenges faced by experts and individuals with type 2 diabetes mellitus (T2DM). Although regular exercise has been shown to improve glycemic control in individuals with T2DM, conventional exercise recommendations are not always feasible for patients due to time constraints. Therefore, "exercise snacking'', which involves short bouts of exercise interspersed throughout the day, has emerged as a potential alternative to traditional exercise regimes. However, optimal intensity, amount, frequency and/or type of "exercise snacking'' for individuals with T2DM remains unclear. The purpose of this three-arm randomized crossover study is to examine the acute effects of different "exercise snacking" modalities on cardiometabolic factors and mental health.MethodsTen sedentary patients (five males and five females, age range: 18-45 years; body mass index (BMI) range: 25-35 kg/m2) diagnosed with T2DM without additional diseases will be recruited. In this crossover study, participants will receive all of the following interventions in a random order: (1) three short sessions of 6 x 1 min of cycling at 90% of maximal heart rate (HRmax) (2) three short sessions of 1 x 20 s of "all out'' sprints at cycle ergometer and (3) no intervention. Glycemic parameters, blood pressure, rate of perceived extraction (RPE), adverse events, enjoyment and affect will be evaluated before and directly after each intervention.DiscussionThe results of this acute study have great potential to inform future public health efforts designed to improve glycemic control, increase exercise rates and affect overall health in individuals with T2DM.Trial registrationThe study was registered on ClinicalTrials.gov (NCT06146036) registred on 18 December, 2023.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial
    Mueller, Stephan
    Dinges, Sophia M. T.
    Gass, Felix
    Fegers-Wustrow, Isabel
    Treitschke, Julian
    von Korn, Pia
    Boscheri, Alessandra
    Krotz, Janosch
    Freigang, Felix
    Dubois, Clara
    Winzer, Ephraim B.
    Linke, Axel
    Edelmann, Frank
    Feuerstein, Anna
    Wolfram, Oliver
    Schaefer, Kerstin
    Verket, Marlo
    Wolfarth, Bernd
    Doerr, Marcus
    Wachter, Rolf
    Hackenberg, Bjoern
    Rust, Sarah
    Nebling, Thomas
    Amelung, Volker
    Halle, Martin
    NATURE MEDICINE, 2025, : 1203 - 1213
  • [22] GlyCemic Control with Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
    Fu, Alex Z.
    Qiu, Ying
    Radican, Larry
    DIABETES, 2010, 59 : A612 - A613
  • [23] Saxagliptin Improves Glycemic Control and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus (T2DM) and Renal Impairment Compared with Placebo
    Owens, David R.
    Swallow, Ros
    Jones, Peter
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    DIABETES, 2010, 59 : A149 - A150
  • [24] Colesevelarn HCI improves glycemic control in type 2 diabetes mellitus (T2DM) subjects managed with insulin therapy
    Goldberg, Ronald B.
    Truitt, Kenneth
    CIRCULATION, 2006, 114 (18) : 306 - 306
  • [25] Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study
    Halter, Jeffrey B.
    Kennedy, Laurence
    Herman, William H.
    Miller, Michael E.
    DIABETES, 2006, 55 : A114 - A115
  • [26] Perspectives on Stringent Glycemic Control and Weight Loss among People with Type 2 Diabetes Mellitus (T2DM) in China
    Zhang, Jian
    Li, Ang
    Quan, Jinxing
    Wu, Jun
    Cai, Hanqing
    Ding, Yuchen
    Tang, Jiani
    Ma, Xiao
    Zhang, Junqing
    DIABETES, 2024, 73
  • [27] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [29] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [30] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208